KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Bausch Health Companies (BHC) over the last 14 years, with Sep 2025 value amounting to $375.5 million.

  • Bausch Health Companies' Shares Outstanding (Diluted Average) rose 1.93% to $375.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $375.5 million, marking a year-over-year increase of 1.93%. This contributed to the annual value of $368.0 million for FY2024, which is 0.85% up from last year.
  • Bausch Health Companies' Shares Outstanding (Diluted Average) amounted to $375.5 million in Q3 2025, which was up 0.54% from $373.5 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) registered a high of $375.5 million during Q3 2025, and its lowest value of $356.8 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $368.4 million, with a median of $368.0 million in 2024.
  • In the last 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) fell by 0.08% in 2022 and then climbed by 1.93% in 2025.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Shares Outstanding (Diluted Average) stood at $358.9 million in 2021, then grew by 0.86% to $362.0 million in 2022, then rose by 0.80% to $364.9 million in 2023, then increased by 0.85% to $368.0 million in 2024, then grew by 1.93% to $375.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $375.5 million for Q3 2025, versus $373.5 million for Q2 2025 and $369.6 million for Q1 2025.